Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study

We investigated the safety, efficacy, and impact of ribavirin and peginterferon dose reduction on complete early virologic response and sustained virologic response (SVR) to triple therapy with telaprevir in treatment-experienced patients with advanced liver fibrosis.Treatment was initiated for 211...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2015-09, Vol.94 (38), p.e1411-e1411
Hauptverfasser: Janczewska, Ewa, Flisiak, Robert, Zarebska-Michaluk, Dorota, Kozielewicz, Dorota, Berak, Hanna, Dobracka, Beata, Librant-Suska, Marta, Lojewski, Wladyslaw, Jurczyk, Krzysztof, Musialik, Joanna, Postawa-Klosińska, Barbara, Wroblewski, Jacek, Augustyniak, Krystyna, Dudziak, Marek, Olszok, Iwona, Ruszala, Agata, Pisula, Arkadiusz, Lapinski, Tadeusz, Kryczka, Wieslaw, Horban, Andrzej, Dobracki, Witold
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We investigated the safety, efficacy, and impact of ribavirin and peginterferon dose reduction on complete early virologic response and sustained virologic response (SVR) to triple therapy with telaprevir in treatment-experienced patients with advanced liver fibrosis.Treatment was initiated for 211 patients who failed treatment with peginterferon and ribavirin, with bridging fibrosis (F3, n = 68) or cirrhosis (F4, n = 143), including 103 (49%) null-responders (NR), 30 (14%) partial responders (PR), and 78 (37%) relapsers (REL). Impaired liver function (ILF) platelets
ISSN:0025-7974
1536-5964
DOI:10.1097/MD.0000000000001411